Canlyniadau Chwilio - Azra Raza

Mireinio'r Canlyniadau
  1. 1
    Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia

    Double labeling and in vitro versus in vivo incorporation of bromodeoxyuridine in patients with acute nonlymphocytic leukemia gan Azra Raza, Kalust Uçar, Harvey D. Preisler

    Cyhoeddwyd 1985
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Myelodysplastic syndromes

    Myelodysplastic syndromes gan Xiaomei Ma, Monique B. Does, Azra Raza, Susan T. Mayne

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986

    Acute myelogenous leukemia with leukemia cutis. Eighteen cases seen between 1969 and 1986 gan Maria R. Baer, Maurice Barcos, Howard Farrell, Azra Raza, Harvey D. Preisler

    Cyhoeddwyd 1989
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies

    Gene-edited stem cells enable CD33-directed immune therapy for myeloid malignancies gan Florence Borot, Hui Wang, Yan Ma, Toghrul Jafarov, Azra Raza, Abdullah Mahmood Ali, Siddhartha Mukherjee

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromes

    Cytogenetic abnormalities in a series of 1029 patients with primary myelodysplastic syndromes gan Olga Pozdnyakova, Patricia M. Miron, Guilin Tang, Ottó Walter, Azra Raza, Bruce A. Woda, Sa A. Wang

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an “angiogenic switch”

    Bone biopsy derived marrow stromal elements rescue chronic lymphocytic leukemia B-cells from spontaneous and drug induced cell death and facilitates an “angiogenic switch” gan Neil E. Kay, Tait D. Shanafelt, Ann K. Strege, Yean Kee Lee, Nancy D. Bone, Azra Raza

    Cyhoeddwyd 2007
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes

    Relationship of Treatment-Related Cytopenias and Response to Lenalidomide in Patients With Lower-Risk Myelodysplastic Syndromes gan Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Aristoteles Giagounidis, Kenton Wride, Robert Knight, Azra Raza, Alan F. List

    Cyhoeddwyd 2008
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes [see comments]

    Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes [see comments] gan Azra Raza, Sefer Gezer, Suneel Mundle, XZ Gao, S. Alvi, Raphael Borok, S. Rifkin, Amna Iftikhar, V. Shetty, Agapi Parcharidou

    Cyhoeddwyd 1995
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Phase <scp>I</scp> clinical trial of oral rigosertib in patients with myelodysplastic syndromes

    Phase <scp>I</scp> clinical trial of oral rigosertib in patients with myelodysplastic syndromes gan Rami S. Komrokji, Azra Raza, Jeffrey E. Lancet, Chen Ren, David R. Taft, Manoj Maniar, François Wilhelm, Alan F. List

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy

    Clinical activity and safety of the dual pathway inhibitor rigosertib for higher risk myelodysplastic syndromes following DNA methyltransferase inhibitor therapy gan Lewis R. Silverman, Peter L. Greenberg, Azra Raza, Matthew J. Olnes, James F. Holland, Premkumar Reddy, Manoj Maniar, François Wilhelm

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats

    Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveat... gan S. A. Wang, Olga Pozdnyakova, Jeffrey L. Jorgensen, L. Jeffrey Medeiros, Dariusz Stachurski, Matthew W. Anderson, Azra Raza, Bruce A. Woda

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Disease-associated mutation in <i>SRSF2</i> misregulates splicing by altering RNA-binding affinities

    Disease-associated mutation in <i>SRSF2</i> misregulates splicing by altering RNA-binding affinities gan Jian Zhang, Yen K. Lieu, Abdullah Mahmood Ali, Alex Penson, Kathryn S. Reggio, Raúl Rabadán, Azra Raza, Siddhartha Mukherjee, James L. Manley

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1

    Disease-Causing Mutations in SF3B1 Alter Splicing by Disrupting Interaction with SUGP1 gan Jian Zhang, Abdullah Mahmood Ali, Yen K. Lieu, Zhaoqi Liu, Jianchao Gao, Raúl Rabadán, Azra Raza, Siddhartha Mukherjee, James L. Manley

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study

    Direct relationship between remission duration in acute myeloid leukemia and cell cycle kinetics: a leukemia intergroup study gan Azra Raza, HD Preisler, Roger Day, Zahida Yasin, Michael White, Joseph Lykins, C Kukla, Maurice Barcos, John M. Bennett, George P. Browman

    Cyhoeddwyd 1990
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes

    The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes gan Francesca Zorat, Vilasini Shetty, Diya Dutt, Laurie Lisak, Fabiana Nascimben, Krishnan Allampallam, Saleem Dar, Aaron York, Sefer Gezer, Parameswaran Venugopal, Azra Raza

    Cyhoeddwyd 2001
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Altered Runx1 Subnuclear Targeting Enhances Myeloid Cell Proliferation and Blocks Differentiation by Activating a miR-24/MKP-7/MAPK Network

    Altered Runx1 Subnuclear Targeting Enhances Myeloid Cell Proliferation and Blocks Differentiation by Activating a miR-24/MKP-7/MAPK Network gan Sayyed K. Zaidi, Christopher R. Dowdy, André J. van Wijnen, Jane B. Lian, Azra Raza, Janet L. Stein, Carlo M. Croce, Gary S. Stein

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic Syndrome

    Deferasirox Reduces Serum Ferritin and Labile Plasma Iron in RBC Transfusion–Dependent Patients With Myelodysplastic Syndrome gan Alan F. List, Maria R. Baer, David P. Steensma, Azra Raza, Jason Esposito, Noelia Martinez-Lopez, Carole Paley, John Feigert, Emmanuel C. Besa

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes

    SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes gan Yen K. Lieu, Zhaoqi Liu, Abdullah Mahmood Ali, Xin Wei, Alex Penson, Jian Zhang, Xiuli An, Raúl Rabadán, Azra Raza, James L. Manley, Siddhartha Mukherjee

    Cyhoeddwyd 2021
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure

    A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure gan Azra Raza, Farhad Ravandi, Anjay Rastogi, Jeffrey A. Bubis, Seah H. Lim, Ilene C. Weitz, Hugo Castro‐Malaspina, Naomi Galili, Rony Abou Jawde, Andrea Illingworth

    Cyhoeddwyd 2013
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia

    A Multicenter Phase I/II Study of Obatoclax Mesylate Administered as a 3- or 24-Hour Infusion in Older Patients with Previously Untreated Acute Myeloid Leukemia gan Aaron D. Schimmer, Azra Raza, Thomas H. Carter, David F. Claxton, Harry P. Erba, Daniel J. DeAngelo, Martin S. Tallman, Carolyn A. Goard, Gautam Borthakur

    Cyhoeddwyd 2014
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: